Genomic Valley Biotech Ltd vs Innovatus Entertainment Networks Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 25.25 as of 24 Mar 13:58 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Innovatus Entertainment Networks Ltd changed from 18.8 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Innovatus Entertainment Networks Ltd changed from ₹ 12.07 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Innovatus Entertainment Networks Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Innovatus Entertainment Networks Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Innovatus Entertainment Networks Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Innovatus Entertainment Networks Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Innovatus Entertainment Networks Ltd

Innovatus Entertainment Networks Limited was originally incorporated with the name Innovatus Entertainment Networks Private Limited' on September 12, 2012.
The Company was converted into a public limited company and name of the Company was changed to Innovatus Entertainment Networks Limited' on January 20, 2022.
A fresh Certificate of Incorporation upon the conversion of the status of the Company was issued on February 24, 2022 by the RoCs, Mumbai. The Company is engaged in the business of providing media/advertising/marketing support services.
In 2013, the Company started the Infotainment business.
It entered into Exhibitions business since year 2018. Under Event Management, the Company services comprise of Entire Event Co-ordination, Pre and Post event Publicity, Production, Printing and Distribution Literature, Venue Research and Booking, Staffing, Guest speakers, Celebrity Management, Transport, Accommodation and Catering, Translators, On-site management, Most advanced technical support, Stage planning, Devising appropriate system for execution and Post event analysis.

FAQs for the comparison of Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Innovatus Entertainment Networks Ltd?

Market cap of Genomic Valley Biotech Ltd is 8 Cr while Market cap of Innovatus Entertainment Networks Ltd is 34 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd?

The stock performance of Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd?

As of March 24, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹28.56. On the other hand, Innovatus Entertainment Networks Ltd stock price is INR ₹14.15.

How do dividend payouts of Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Innovatus Entertainment Networks Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.